The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.d

Organizing pneumonia pattern (an area or areas of consolidation on imaging)

Publications

Lee EJ, Lee SY, In KH, Kim CH, Park S

Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2012;21(1):89-92

Masetti R, Cazzato S, Prete A, Rondelli R, Di Vincenzo AO, Pession A

Organizing pneumonia primed by high-dose chemotherapy and lung irradiation: two pediatric cases.

Journal of pediatric hematology/oncology. 2011;33(5):e202-4

Dodd JD, Lee KS, Johkoh T, Müller NL

Drug-associated organizing pneumonia: high-resolution CT findings in 9 patients.

Journal of thoracic imaging. 2006;21(1):22-6

Aguiar Bujanda D, Aguiar Morales J, Bohn Sarmiento U

[Bronchiolitis obliterans organizing pneumonia induced by chemotherapy].

Archivos de bronconeumologia. 2004;40(6):290

Helton KJ, Kuhn JP, Fletcher BD, Jenkins JJ 3rd, Parham DM

Bronchiolitis obliterans-organizing pneumonia (BOOP) in children with malignant disease.

Pediatric radiology. 1992;22(4):270-4